pBABEpuro HA Brca1 Citations (11)
Originally described in: Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.Cortez D, Wang Y, Qin J, Elledge SJ Science. 1999 Nov 5. 286(5442):1162-6. PubMed Journal
Articles Citing pBABEpuro HA Brca1
| Articles |
|---|
| BRCA1 regulates PIG3-mediated apoptosis in a p53-dependent manner. Zhang W, Luo J, Chen F, Yang F, Song W, Zhu A, Guan X. Oncotarget. 2015 Apr 10;6(10):7608-18. PubMed |
| Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis. Fan S, Liu B, Sun L, Lv XB, Lin Z, Chen W, Chen W, Tang Q, Wang Y, Su Y, Jin S, Zhang D, Zhong J, Li Y, Wen B, Zhang Z, Yang P, Zhou B, Liang Q, Yu X, Zhu Y, Hu P, Chu J, Huang W, Feng Y, Peng H, Huang Q, Song E, Li J. Oncotarget. 2015 Jun 20;6(17):14885-904. PubMed |
| BRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1. Zhang W, Luo J, Yang F, Wang Y, Yin Y, Strom A, Gustafsson JA, Guan X. Sci Rep. 2016 Feb 23;6:22034. doi: 10.1038/srep22034. PubMed |
| The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer. Luo J, Jin J, Yang F, Sun Z, Zhang W, Shi Y, Xu J, Guan X. Int J Biol Sci. 2016 Nov 25;12(12):1500-1510. eCollection 2016. PubMed |
| Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention. Chiyoda T, Hart PC, Eckert MA, McGregor SM, Lastra RR, Hamamoto R, Nakamura Y, Yamada SD, Olopade OI, Lengyel E, Romero IL. Cancer Prev Res (Phila). 2017 Apr;10(4):255-266. doi: 10.1158/1940-6207.CAPR-16-0281. Epub 2017 Mar 6. PubMed |
| BRCA1 regulation on beta-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer. Sengodan SK, Nadhan R, Nair RS, Hemalatha SK, Somasundaram V, Sushama RR, Rajan A, Latha NR, Varghese GR, Thankappan RK, Kumar JM, Chil A, Anilkumar TV, Srinivas P. Oncogenesis. 2017 Sep 4;6(9):e376. doi: 10.1038/oncsis.2017.75. PubMed |
| BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage. Biswas K, Philip S, Yadav A, Martin BK, Burkett S, Singh V, Babbar A, North SL, Chang S, Sharan SK. Nat Commun. 2018 Feb 7;9(1):537. doi: 10.1038/s41467-018-03020-6. PubMed |
| PP2Cdelta inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer. Li Q, Hao Q, Cao W, Li J, Wu K, Elshimali Y, Zhu D, Chen QH, Chen G, Pollack JR, Vadgama J, Wu Y. Sci Adv. 2019 Oct 16;5(10):eaaw8417. doi: 10.1126/sciadv.aaw8417. eCollection 2019 Oct. PubMed |
| Colocalization of BRCA1 with Tau Aggregates in Human Tauopathies. Kurihara M, Mano T, Saito Y, Murayama S, Toda T, Iwata A. Brain Sci. 2019 Dec 20;10(1). pii: brainsci10010007. doi: 10.3390/brainsci10010007. PubMed |
| Proteosomal degradation of NSD2 by BRCA1 promotes leukemia cell differentiation. Park JW, Kang JY, Hahm JY, Kim HJ, Seo SB. Commun Biol. 2020 Aug 21;3(1):462. doi: 10.1038/s42003-020-01186-8. PubMed |
| STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer. Wang Q, Bergholz JS, Ding L, Lin Z, Kabraji SK, Hughes ME, He X, Xie S, Jiang T, Wang W, Zoeller JJ, Kim HJ, Roberts TM, Konstantinopoulos PA, Matulonis UA, Dillon DA, Winer EP, Lin NU, Zhao JJ. Nat Commun. 2022 May 31;13(1):3022. doi: 10.1038/s41467-022-30568-1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.